Suraksha Diagnostic has debuted at Rs 437.00 on the BSE, down by 4 points or 0.91% from its issue price of Rs 441.00.
The scrip is currently trading at Rs 433.05, down by 7.95 points or 1.80% from its issue price.
It has touched a high and low of Rs 449.00 and Rs 426.65 respectively. So far 2.46 lakh shares were traded on the counter.
The offering, which was open for subscription between November 29, 2024 and December 03, 2024 was subscribed 1.27 times. The issue price was fixed at Rs 441.00 per share i.e. at upper end of price band of Rs 420-441 apiece.
Suraksha Diagnostic is primarily engaged in the business of running diagnostic centres for carrying out various pathological and radiological services.
| Company Name | CMP |
|---|---|
| Apollo Hospital Ent. | 7725.65 |
| Max Healthcare Inst | 999.35 |
| Narayana Hrudayalay | 1770.00 |
| Aster DM Healthcare | 705.40 |
| Global Health | 1105.85 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: